The IPAB ruling in favour of the Natco Pharma against Bayer has reignited the debate over innovation versus access in the health sector.
India today invoked a WTO provision and permitted Hyderabad-based Natco Pharma to manufacture and sell cancer-treatment drug Nexavar.
Day in Pics: 31st January
Showbiz World - January 31, 2015
Playboy Super Bowl XLIX Party